$MNK Q3 Numbers were affected by a strategic investment in silcence therapeutics, MNK has the rights for up to 3 key products. Well here is the cool news: they paid 20m upfront for the rights. and another 5m for a 6.5% stake in silence. NOW since they took that stake the stock 5-folded. Which makes the 6.5% stake worth 25m+ . So they got the rights for free :)
  • 6
  • 3